Live Breaking News & Updates on Institute of nuclear medicine

Stay informed with the latest breaking news from Institute of nuclear medicine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Institute of nuclear medicine and stay connected to the pulse of your community

Covid-19: How effective are the new treatments approved by India?

Covid-19: How effective are the new treatments approved by India?
scroll.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scroll.in Daily Mail and Mail on Sunday newspapers.

United-states , Cumballa-hill , Maharashtra , India , Mumbai , Hyderabad , Andhra-pradesh , Mahatma , Rajasthan , Switzerland , Swiss , Gunjan-chanchalani

TIL: How Effective Are The New COVID-19 Treatments?

TIL: How Effective Are The New COVID-19 Treatments?
Indian and international regulators have approved a monoclonal antibody cocktail and the drug tocilizumab for Covid-19 treatment, but only India has approved the use of 2-deoxy-D-glucose.
By
Print
Chandigarh: On July 6, 2021, the World Health Organization (WHO) approved two rheumatoid arthritis drugs, tocilizumab and sarilumab, to treat Covid-19. "These are the first drugs found to be effective against COVID-19 since corticosteroids were
said in a press release.
Tocilizumab has been part of India's guidelines since June 2020, as an investigational therapy for Covid-19. In May 2021, the Indian government also approved two new Covid-19 treatments for emergency use: a

Cumballa-hill , Maharashtra , India , Mumbai , Hyderabad , Andhra-pradesh , Mahatma , Rajasthan , Switzerland , Swiss , Gunjan-chanchalani , Regeneron-pharmaceuticals

MSN Laboratories enters into licence agreement with DRDO for 2 DG

MSN Laboratories enters into licence agreement with DRDO for 2 DG
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

India , Defence-research-development-establishment , Union-health-ministry , Institute-of-nuclear-medicine-allied-sciences , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Development-establishment , Nuclear-medicine , Allied-sciences , Drug-controller-general

MSN Labs enters into license agreement with DRDO for 2-DG

MSN Labs enters into license agreement with DRDO for 2-DG
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Defence-research-development-establishment , Ltd-on , Institute-of-nuclear-medicine , Defence-research-development-organisation , Defence-research , Development-establishment , Nuclear-medicine , Allied-sciences

MSN inks license pact with DRDO for manufacturing, distribution and marketing of 2-DG

MSN inks license pact with DRDO for manufacturing, distribution and marketing of 2-DG
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Defence-research-development-establishment , Institute-of-nuclear-medicine , Defence-research-development-organisation , Defence-research , Development-establishment , Nuclear-medicine , Allied-sciences , Development-organisation

MSN Labs enters into licence deal with DRDE for Covid-19 drug 2-DG

MSN Labs enters into licence deal with DRDE for Covid-19 drug 2-DG
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

India , Defence-research-development-establishment , Institute-of-nuclear-medicine , Defence-research , Development-establishment , Drug-controller-general , Nuclear-medicine , Allied-sciences , இந்தியா , பாதுகாப்பு-ஆராய்ச்சி-வளர்ச்சி-ஸ்தாபனம் , நிறுவனம்-ஆஃப்-அணு-மருந்து

Mankind Pharma Gets DRDO Nod To Manufacture, Sell COVID-19 Drug 2-DG

Mankind Pharma Gets DRDO Nod To Manufacture, Sell COVID-19 Drug 2-DG
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.

India , Himachal-pradesh , Visakhapatnam , Andhra-pradesh , Development-establishment , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Mankind-pharma-gets , Sell-covid-drug , Mankind-pharma

2dg drug: Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG

2dg drug: Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

India , Himachal-pradesh , Visakhapatnam , Andhra-pradesh , Development-establishment , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Mankind-pharma , Nuclear-medicine , Allied-sciences

Mankind Pharma gets DRDO nod to manufacture, market covid drug 2-DG

Mankind Pharma gets DRDO nod to manufacture, market covid drug 2-DG
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

India , Himachal-pradesh , Visakhapatnam , Andhra-pradesh , Dr-reddy-laboratory , Development-establishment , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Mankind-pharma , Nuclear-medicine

Bajaj Healthcare share price: Bajaj Healthcare soars 11% on receiving DRDO licence to manufacture and market oral Covid drug

Bajaj Healthcare share price: Bajaj Healthcare soars 11% on receiving DRDO licence to manufacture and market oral Covid drug
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

India , New-delhi , Delhi , National-stock-exchange-of-india , Institute-of-nuclear-medicine , Development-organisation , Defence-research , Bajaj-healthcare , Nuclear-medicine , Allied-sciences , Drugs-controller-general